Identification of prognostic factors predicting the long-term clinical outcome in Multiple Sclerosis
Multiple Sclerosis (MS) evolution varies from benign to aggressive forms, and its prognosis remains largely unpredictable, especially in individual cases. Relapse frequency is commonly used as indicator of disease activity and as primary endpoint in randomized clinical trials (RCTs). However, the ro...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.666468 |